Z 103

Known as: Z-103 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Z-103 is a chelate compound consisting of zinc ion and L-carnosine. In this study, we investigated the protective effect of Z-103… Expand
Is this relevant?
1992
1992
Z-103 at 1 to 25 mg/kg, p.o. prevented 100% ethanol-induced gastric mucosal lesions in a dose-dependent manner. Z-103 at 3 to 25… Expand
Is this relevant?
1992
1992
The gastric mucosal adhesiveness of Z-103 in rats with acetic acid ulcer was studied macroscopically, histologically, and… Expand
Is this relevant?
1991
1991
Zinc compounds have been shown to antagonize various types of gastric ulceration in rats. Zinc carnosine (Z-103), a newly… Expand
Is this relevant?
1991
1991
The protective effect of a novel synthetic zinc-carnosine chelate compound, zinc N-(3-aminopropionyl)-L-histidine (Z-103), on the… Expand
Is this relevant?
1991
1991
A zinc-carnosine chelate compound, Z-103, attenuates gastric mucosal injuries and inhibits the increase of lipid peroxide in the… Expand
Is this relevant?
1990
1990
We investigated the anti-ulcer effects of zinc L-carnosine (Z-103) using several acute experimental models of gastric and… Expand
Is this relevant?
1990
1990
In the healing test of acetic acid ulcers in rats with limited food-intake-time, Z-103 given, p.o., at doses of 3 and 10 mg/kg… Expand
Is this relevant?
1990
1990
The objective of the present study was to examine the anti-free radical action of Z-103 in vitro. Z-103 is a novel synthetic… Expand
Is this relevant?
1989
1989
Z-103 (a novel anti-ulcer agent), given p.o. at doses of 30 and 100 mg/kg, significantly prevented gastric lesions induced by… Expand
Is this relevant?